Hey guys! Today, we'll cover Part 2 of our discussion on MindMed's (MMED / MNMD / MMQ) conference call.
In the previous episode, we talked about the progress MindMed has made up until this point, MindMed's mission, talent Acquisition, and the progress of their clinical trials.
In today's episode, we will take a more futuristic approach and examine the future plans discussed in MindMed's Q1 conference call. We will cover topics such as:
A. Where is MindMed going?
B. What is MindMed 2.0?
C. What will MindMed in 3 years time look like as compared to now?
Over the next several years, we expect 4 transformations to occur.
1. MindMed’s transition to a tech company, from a pharmaceuticals company;
2. The shift from classic psychedelics like LSD to “next generation” patent protected substances;
3. Reorientation away from one size fits all medical solutions towards personalized medicine;
4. Finding Partnerships with major pharmaceutical companies.
Timestamps:
0:00 - Intro
2:16 - MindMed transitioning to a tech company
7:14 -Next-gen shift
12:11 - Personalized medicine
13:59 - Partnerships
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #MNMD #MindMedstock
Psychedelic Business Roundup- Key Psychedelic Industry Leader Joins The NASDAQ
Psychedelic Spotlight VideosTexas Senate Approves Psychedelic Research Legislation Aimed at Military Veterans
PolicyEnveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries
BusinessCalifornia Bill Decriminalizing Psychedelics Moves Closer to Full Senate Vote
PolicyIndustry NEWS: The GOOD, The BAD, And The UGLY / New Psychedelic Studies, Legalization Bills & MORE!
VideosPsychedelic Passage Bridges Gap Between Guide and Journeyer
TreatmentPsychedelic Business Spotlight: May 21, 2021
BusinessMindMed: What Does The Future Hold? ( MMED/ MNMD )
VideosActress Kristen Bell Used Psychedelic Mushrooms to Treat Depression
CultureShark Tank’s Kevin O’Leary Deep Dives Into Psychedelics
Business